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Different immunoassay-based methods have been devised to detect protein targets. These methods have some
challenges that make them inefficient for assaying ultra-low-amounted proteins. ELISA, iPCR, iRCA, and iNASBA are
the common immunoassay-based methods of protein detection, each of which has specific and common technical
challenges making it necessary to introduce a novel method in order to avoid their problems for detection of target
proteins. Here we propose a new method nominated as ‘immuno-loop-mediated isothermal amplification’ or
‘iLAMP’. This new method is free from the problems of the previous methods and has significant advantages over
them. In this paper we also offer various configurations in order to improve the applicability of this method in real-
world sample analyses. Important potential applications of this method are stated as well.
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Proteins are biomolecules that have critical roles in living
organisms. There are various types of proteins. Each type
has a specific role in their corresponding organisms. The
physiological status of organism determines the type and
the concentration of a specific protein [1]. Also in the
pathologic state, some variations occur in the type as well
as concentration of proteins, depending on the type of
pathological condition. For example, infectious diseases
produce proteins that do not exist in healthy organisms
[2]. Furthermore, in non-infectious diseases some proteins
are produced not found in the healthy organism. These
proteins are called biomarkers, and due to their specificity
they can be applied in monitoring related disease. In
addition to the disease-related proteins, other biologically
important proteins need to be assayed [3].
Various methods are used for detection and quantifica-
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distribution, and reproduction in any medium,methods are immunoassay-based techniques, which are
divided into enzyme-substrate reactions, such as
enzyme-linked immunosorbent assay (ELISA), and signal
DNA amplification-based methods of protein detection,
such as immuno-polymerase chain reaction (iPCR) [4,5].
ELISA is routinely used for assaying various proteins.
The technique has some limitations. The most import-
ant limitation is its low sensitivity in detecting ultra-low-
concentrated proteins [6,7]. On the other hand, signal
DNA amplification-based methods have several advan-
tages, including easy preparation of nucleic acids and
specificity of sequence of signal DNA and its easy ampli-
fication [8]. For this reason, it has emerged as a powerful
technique, known as ‘immuno-PCR’ or ‘iPCR’ through
introduction of 100 to 10,000 times more sensitivity for
detection of target proteins compared with routine
ELISA [9]. Although iPCR have been designed to detect
many proteins [10-19], it may suffer from important lim-
itations including complicated protocol as well as re-
quirement of special instruments and well-trained
laboratory personnel. Therefore, it became necessary to
design novel techniques to overcome the problems of
iPCR [20]. Beyond iPCR other similar techniques have
been proposed for detection of protein molecules with
DNA as signal molecules. iReal-time PCR, immuno-
rolling circle amplification (iRCA), and immuno-nucleicSpringer. This is an Open Access article distributed under the terms of the
reativecommons.org/licenses/by/2.0), which permits unrestricted use,
provided the original work is properly cited.
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mon examples of such methods. These methods have
their own limitations as well, as discussed below.
In this study, we propose a new method for protein de-
tection. The proposed method comprises of two main
steps, including signal amplification step, called immuno-
loop-mediated isothermal amplification (immuno-LAMP
or iLAMP), followed by ultra-sensitive detection of ampli-
fied signal. Here we discuss the main aspects of this new
technique while comparing it with current nucleic acid-
based detection methods for proteins.
The hypothesis and its evaluation
Immuno-LAMP
Loop-mediated isothermal amplification (LAMP) is a
new method developed in year 2000 by Notomi et al. Ba-
sically, this method of DNA amplification uses a specific
DNA polymerase enzyme and a set of four specific
primers that distinguish six different regions on the se-
quence of the target DNA. The primers consist of inner
primer pair [FIP (forward inner primer) and BIP (back-
ward inner primer)] and outer primer pair [F3 (forward
outer primer) B3 (backward outer primer)]. Inner
primers contain sequences of the sense and antisense
strands of the target, while outer primers contain only
the antisense sequence of the target strands. In the first
step of LAMP, an inner primer starts the reaction and
the newly produced strand is displaced by annealing of
an outer primer on the same target strand and subse-
quent synthesis of complementary product strand. The
displaced product strand (primed by inner primer) itself
serves as template for synthesis of new strand primed by
the second inner and outer primers, which hybridize to
the other end of the target DNA; the strand adopts
stem-loop structure. The next round of LAMP reaction
produces a new stem-loop DNA structure, which has a
stem twice as long. The reaction continues until accu-
mulation of stem-loop DNA structures with several
inverted repeats of the target and cauliflower-like struc-
tures with multiple loops formed by annealing between
alternately inverted repeats of the target in the same
strand. The reaction takes less than an hour, and pro-
duces 109 copies of the target DNA [21].
Due to its significant advantages over PCR, since its
development, LAMP has been found in many applica-
tions in the molecular diagnosis including detection of
pathogens, genetically modified organisms, embryo sex
detection, and tumor detection [22]. One advantage is
that in LAMP method, a particular bacterial DNA poly-
merase, named Bst DNA polymerase, is used for amplifi-
cation of the target in isothermal condition without
application of any specific thermal cycler. Because this
enzyme denatures simultaneously the substrate double-
strand DNA and subsequently synthesizes products,there is no need for pre-denaturation of target dsDNA,
especially by heat, which is used commonly in PCR tech-
nique. The amplification thus can be performed in a
simple water bath or other heating tool in isothermal
condition.
Secondly, in spite of PCR, products of LAMP can be
detected visually by the naked eye through turbidity or
adding DNA intercalating dyes (e.g., SYBR green) with-
out any need for specified equipment (gel electrophor-
esis and UV gel documentation systems which are
necessary in PCR). Also, since the amplification and de-
tection are performed in the same tube, unlike PCR,
LAMP can be performed in closed reaction tubes and it
minimizes any cross-contamination risk while using
multiple samples [21,23-25]. Besides this advantage,
LAMP is not as sensitive as PCR toward inhibitors [26].
It thus contributes to lowering of LAMP costs compared
with PCR.
The third advantage is the higher specificity and sensi-
tivity of LAMP over PCR. Unlike common PCR, per-
formed using one pair of primer, LAMP requires at least
two pairs of primer and, thus, increases the chance of
specific recognition and amplification of target DNA
compared to PCR. Higher sensitivity of LAMP originates
from the unique mechanism of amplification, known as
loop-mediated amplification, which produces huge
amplicons consisting of repeated loop-shaped and
dumbbell-like DNA structures. This type of amplicons
allows easier detection of positive results and lowers the
limit for detection. Therefore, it increases sensitivity of
LAMP in comparison with PCR. The fourth advantage
of LAMP is its speed over PCR. The overall time for car-
rying out LAMP is about 1 h compared with 2 to 4 h in
PCR [21,23-25] Moreover, the rate of LAMP reaction
can be increased by using two additional primers, called
loop primers [27]. Therefore, LAMP is considered a
more rapid molecular technique compared with PCR.
LAMP can be performed in a high-throughput format
for simultaneous analysis of large-number samples in
96-well microplate [28]. Lower cost, quickness, simpli-
city, specificity, and sensitivity make LAMP a powerful
alternative for PCR in the field of molecular diagnosis,
especially in developing countries. Therefore, consider-
ing the advantages of LAMP over PCR, it can be used in
most of molecular methods that utilize PCR. One of the
molecular methods, which can use LAMP instead of
PCR, is ‘immuno-PCR’ or ‘iPCR’. iPCR is usually used
for detection as well as quantification of antigens (Ags),
which are mostly protein, using PCR. In this method tar-
get Ag is captured in a sandwich form between two anti-
bodies (Abs), the capture antibody and the detection
antibody, which are specifically bound to the target anti-
gen. The capture Ab, which is pre-immobilized on a
solid support surface, captures the target Ag, and the
Figure 1 The principle of iLAMP reaction.
Pourhassan-Moghaddam et al. Nanoscale Research Letters 2013, 8:485 Page 3 of 11
http://www.nanoscalereslett.com/content/8/1/485detection Ab, which is pre-conjugated with a double-
strand DNA called signal DNA, attaches to the captured
Ag. After wash, the signal DNA is amplified by PCR,
and hence the presence of PCR products indicates indir-
ectly the presence of target Ag in the sample. In fact, in
iPCR, PCR is used for signal amplification. Since PCR
method produces millions of copies of target DNA, iPCR
converts the presence of a few Ag molecules into a sig-
nal, which is easily detectable. Thus, iPCR can detect Ag
in very low quantities and is more sensitive than com-
mon Ag detecting methods like ELISA [9]. However,
iPCR itself may have some technical limitations. Some
practical drawbacks make this method difficult to be
easily utilized in low-resource laboratories. These limita-
tions include complicated and time-consuming protocol,
requirement for specific tools and expert personnel for
performing of the method, low signal-to-noise ratio, the
risk of cross-contamination among different samples
when assaying multiple samples, and technical hurdles
in the preparation of detection of antibody-signal DNA
conjugates. The real-time iPCR also requires advanced
thermal cyclers and more specified reagents compared
with iPCR [20].
iRCA is another version of nucleic acid-based method
for protein detection. In this technique, a specific DNA
polymerase enzyme is used to elongate the primer DNA,
which hybridizes to a circular DNA as the template [8].
This technique has been used for detecting prostate-
specific antigen [29], as well as simultaneous detection
of cytokines' and allergens' specific antibodies in a
microarray format [30-32], and introduced commercially
for chip-based amplification [20]. Some disadvantages of
iRCA are common with iPCR. These limitations include
cumbersome preparation of antibody-signal DNA conju-
gates, complicated and time-consuming protocol, risk of
cross-contamination among different samples, no quan-
tification capacity of rolling circle amplification (RCA)
reaction, complex primer design, and no tolerance to
complex biological environment [33].
Another form of nucleic acid-based protein detection
is known as iNASBA, which has been used for high-
throughput detection of adrenocorticotropic hormone
and two common waterborne pathogens, Escherichia
coli and Rotavirus, in 96-well microplate format [34].
Nucleic acid sequence-based amplification (NASBA)
technique has some limitations over LAMP method.
Firstly, a suitable substrate for NASBA reaction is RNA,
while that for LAMP is DNA. Instability of RNA makes
LAMP more appropriate for application in protein tar-
gets. The second limitation of NASBA originates from
the requirement of reverse transcriptase, RNase H, and
T7 DNA-dependent RNA polymerase during reaction,
but in LAMP only DNA polymerase is needed. The third
limitation is that products of NASBA are RNAmolecules and gel electrophoresis is necessary to detect
them. This makes NASBA more liable and dependent
on special equipments. There is no need for gel electro-
phoresis for detection of LAMP products, which are DNA
molecules. Moreover, due to the instability of NASBA
products, quantification of iNASBA is not easy in com-
parison with iLAMP products. Although the amplification
reaction of NASBA is isothermal, a single melting step
prior to the amplification reaction is required to allow an-
nealing of the primers to the target, which is not required
in LAMP [35,36].
Considering the advantages of LAMP over PCR, RCA,
and NASBA methods, one can believe that LAMP can
be used instead for detection of Ags. We name this
method ‘immuno-loop-mediated isothermal amplifica-
tion’ or ‘iLAMP.’ This novel method can detect Ags, for
instance proteins, with ultra-specificity and sensitivity as
well as rapidness, low cost without the need for expert
personnel, and advanced instruments in comparison
with ELISA, iPCR, iRCA, and iNASBA [23]. In this
novel technique, the target protein is first captured by
specific antibody or aptamer, and the second specific
antibody or aptamer recognizes the captured protein.
This secondary antibody is pre-conjugated with a known
DNA sequence that is amplified in the subsequent
LAMP reaction after release from the secondary anti-
body. In the case of aptamer, it is possible to directly use
it as the substrate for the LAMP due to the fact that it is
nucleic acid and it can be easily amplified by LAMP re-
action (Figure 1).
Table 1 summarizes the main features of the men-
tioned techniques and iLAMP.
Possible configurations of iLAMP
iLAMP can be modified as different platforms in order
to enhance its capabilities. Amplification of signal DNA
by LAMP is considered as the first step of signal amplifi-
cation, which is achieved through performing LAMP
followed by detection of LAMP products by common
methods, such as turbidimetry, inspection by naked eye,




















iLAMP Low Low No Low High High Yes Yes Yes Low
iPCR High High Yes High Intermediate-high Intermediate-high No No No High
iReal-time PCR High High Yes High Intermediate-high Intermediate-high Yes No No High
iRCA High High Yes High High Intermediate-high Yes Yes No High
iNASBA High High Yes High High Intermediate-high Yes Yes No High
ELISA High High Yes High Low Low Yes Yes No High
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methods can also be applied to the detection of iLAMP
amplification product.
Sometimes further amplification of the signal may be
necessary, particularly in the case of detecting trace pro-
teins. In these cases, it can be achieved by enhancing the
detection of LAMP products through more sensitive
methods. Application of nanoprobes, integration with
signal DNA-containing liposome, and microfluidic tech-
nology can increase the sensitivity and selectivity of
iLAMP.
Also, some modifications can be implemented into
iLAMP to improve its performance, such as integration
with microfluidic technology and application of apta-
mers instead of antibodies for capturing as well as detec-
tion of target proteins. A number of potentially
important modifications are discussed below.
Integration with nanoprobes
Nanoprobes are nanoscale tools, which are used for de-
tecting and monitoring various molecular targets. In bio-
logical purposes, they can be designed to detect
biomacromolecules, such as DNA, RNA and proteins.
They are composed of sensor and detector part. Sensor
part is used to signal the presence of target molecule,
while the detector part recognizes the target molecule.
This recognition is based on the specific interaction of
target molecule with the detection part of the nanop-
robe. For detection of DNA and RNA, the detector part
is a strand of nucleic acid, which specifically hybridizes
with target DNA or RNA molecule. Nanoparticle-based
nanoprobes are excellent tools for detection of nucleic
acids. They have a nanoparticle (as sensory part) and
probe part (as detection part).
In regards to the fact that the product of iLAMP is
DNA, molecular nanoprobes can be utilized to detect it.
The application of nanoprobes adds further sensitivity
and specificity to iLAMP. Considering the fact that the
sequence of iLAMP products can be inferred from the
sequence of signal DNA, nanoprobes can be easily
designed for specific detection of iLAMP products.
Application of these nanoprobes can have potentialadvantages. Firstly, application of probes makes this
method more specific than other current methods. Sec-
ondly, color change can be easily quantified by simple
spectrophotometry or colorimetry based on color inten-
sities, so that color intensities indirectly can be corre-
lated with concentration of target protein [37]. This
format is called ‘iLAMP-nanoprobe’ method and can be
an appropriate alternative for real-time iPCR, which is
used for quantification or determination of the primary
concentration of target protein. Real-time iPCR has sig-
nificant pitfalls which iLAMP-nanoprobe method does
not have. These pitfalls include high cost, requirement
of expert personnel, advanced instruments, and much
time [20]. Thus, in addition to qualitative iPCR and
other similar methods, iLAMP-Au-nanoprobe method
can be used instead of real-time iPCR.
Different nanoparticle-based nanoprobes have been
designed so far. Gold, silver, and quantum dot (fluores-
cent) nanoparticles are main nanoparticles that are used
for detection of target nucleic acids.
Gold nanoprobes (Au nanoprobes) Gold-nanoparticle
probes take the optical advantages of gold nanoparticles
at the time of specific hybridization between their nu-
cleic acid parts with target nucleic acids. The
hybridization brings the gold nanoparticle part of these
probes near each other, leading their aggregation and
subsequent color change from deep red to blue/purple
[38].
Generally, two main formats are used to detect target
DNA by Au nanoprobes called ‘homogenous’ or ‘solu-
tion-based’ format and ‘heterogenous’ or ‘solid-based’
format. In the homogenous format, the hybridization of
Au nanoprobes with target occurs homogenously with-
out any attachment to any solid supports. However, in
the heterogenous format the recognition of target se-
quence occurs on a specific probe sequence linked to a
solid support. The routine method of target detection
using heterogenous format is a sandwich-type reaction,
in which target sequence is hybridized with two specific
probes, so that one probe is attached to a solid base;
after hybridization of target sequence, the secondary
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target sequence. The presence of specific target is de-
tected then by the use of silver enhancement. This for-
mat of detection shows more sensitivity and specificity
for recognition of target nucleic acid compared with
homogenous format [38]. Although silver enhancement has
some drawbacks, the results can be quantified based on the
intensities of reduced silver. The drawbacks are high back-
ground of silver enhancement and weak signal-to-noise ra-
tio [39]. However, these can be avoided by using gold
enhancement instead of silver enhancement. Gold enhance-
ment has been used in two studies for detecting target nu-
cleic acid in homogenous format [40,41]; and due to the
high false-positive results associated with silver enhance-
ment [39], gold enhancement can be used for the detection
of target nucleic acids in heterogenous format and can be
applied for quantitative detection of iLAMP products by
Au nanoprobes in iLAMP-Au-nanoprobe method. Another
advantage of heterogenous format is its applicability for
simultaneous, high-throughput assay of several samples.
This can be achieved using 96-well or 384-well microplates
so that each single well can be a site for one reaction.
Another type of solid-base format is the application of
paper strips for detection of targets by Au nanoprobes
[34]. Although this type does not allow quantification, it
can be used to read out results of iLAMP-Au-nanoprobe
method beside previously described homogenous and
heterogenous formats.
Recently, some studies have shown the advantages of
Au nanoprobes to detect LAMP product. In these stud-
ies, LAMP products were specifically hybridized with Au
nanoprobes, and upon hybridization the color of reac-
tion was changed from red to blue [42-44].
Accordingly, regarding the advantages and application
of Au nanoprobes for detection of LAMP products, the
aforementioned formats can be used for detecting
iLAMP products in iLAMP-Au-nanoprobe method.
Silver nanoprobes (Ag nanoprobe) Silver nanoparticles
(Ag) have analogous properties to gold nanoparticles.
Thus, they have been used in two recent studies to pre-
pare Ag nanoprobes for the detection of target DNA
molecules [45,46]. In these studies, the presence of tar-
get DNA was detected by spectral changes in surface
plasmon resonance of gold nanoparticles and visual in-
spection. The advantage of Ag nanoprobes over Au
nanoprobes is that due to the greater extinction coeffi-
cient of silver nanoparticles in comparison with gold
nanoparticles, much lower concentrations of Ag nanop-
robes are required to analyze spectral absorption, and
thus the sensitivity of Ag nanoprobes are more than that
of Au nanoparticles with the same concentration.
Like Au nanoparticles, silver/gold enhancement can
also be applied at the time of target DNA detection withAg nanoprobes in order to increase the sensitivity as
well as to make the quantification because Ag and Au
nanoparticles have similar optical properties [47].Gold-silver alloy nanoprobes (Au-Ag nanoprobes)
Au-Ag nanoprobes have the optical properties of silver
nanoparticles (high extinction coefficient) with ease of
functionalization via a thiol bond provided by the gold
at the same time. Preparation of the alloy nanoparticles
solves the problems associated with the functionalization
of Au and Ag composite nanoparticles while retaining
the beneficial properties for DNA detection [48].
Moreover, it is possible to use Au-Ag nanoprobes and
Au nanoprobes inside the same reaction to detect simul-
taneously two different targets. This capability is due to
different optical properties of Ag-Au alloy nanoparticles
with Au nanoparticles, which makes it possible to per-
form multiplex assays. Detection of more targets simul-
taneously can be possible through application of alloys
with different Ag/Au ratios [48]. This property can be
exploited in iLAMP method for designing multiplex as-
says that detect different protein targets simultaneously.Quantum dot (fluorescent) nanoprobes Quantum dots
(QDs), the semiconductor nanocrystals with 100 to
100,000 numbers of atoms, have unique optical proper-
ties. They are relatively photostable in comparison with
common fluorescent dyes. These properties make them
attractive candidates for designing optical nanoprobes
and, thus, are used in real-time and continuous detection
of target molecules. The most common method of using
QDs as nanoprobes is utilizing them in order to create an
‘on/off ’ signal via Förster resonance energy transfer
(FRET) phenomena whereby non-radioactive energy
transfer occurs between the QD (donor) and an acceptor
molecule (quencher), while monitoring molecular dis-
tances and interactions at the nanoscale level [49-51].
Different methods of target DNA detection has been
used using FRET phenomena. Most of these methods
are based on the hybridization between target DNA and
QD-tagged probes (QD nanoprobes). These probes are
usually double-tagged with QD (in one end) as well as a
quencher molecule (in the other end). As mentioned
previously, these nanoprobes can be designed to produce
signal (signal on) or disappear the signal of tagged QD
molecule (signal off ) when they recognize target DNA.
In the signal-on method the probe DNA is designed as
stem-loop structure. In this state QD is located in the
vicinity of quencher molecule, absorbing the fluorescent
signal of QD and preventing it from detection. However,
when the nanoprobe hybridizes with the target DNA,
the stem-loop structure denatures and is converted to
the linear conformation. The QD and quencher
Figure 2 The principle and possible ways of iLAMP products analysis with different nanoprobes (nanoprobe-iLAMP platform).
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it possible to detect the fluorescent signal of tagged QD.
In the signal-off method, the nanoprobe is tagged with
QD and the target is tagged with quencher. In unhybridized
state, the tagged QD emits signal and its signal is detectable.Figure 3 Integration of liposome with iLAMP (liposome-iLAMP platfoBut when the nanoprobe recognizes the target DNA, it hy-
bridizes the target DNA, leading to bringing QD to the
vicinity of quencher and prevention of QD emission [52].
QDs can also be used as electroactive labels for detec-
tion of target DNA in the electrochemical biosensors.rm).
Pourhassan-Moghaddam et al. Nanoscale Research Letters 2013, 8:485 Page 7 of 11
http://www.nanoscalereslett.com/content/8/1/485This property originates from inherent electrochemical
properties with ease of miniaturization, low cost, low
power requirements, and excellent biocompatibility. In
electrochemical detection of target DNA molecules by
QDs, they serve as electrochemical catalyst (electroactive
molecules), which transports loads of electrons through
the reduction of dissolved oxygen, resulting in a signifi-
cant increase in the reduction peak current. In fact, they
show sharp voltammetry signals proportional to the con-
centration of corresponding DNA targets and serve as
signal-enhancing agents [53].
In addition to detection of one target, several
different-sized QD molecules can be excited by one exci-
tation source simultaneously. This ability is advanta-
geous in detecting more than one target in the same
time [54]. It is thus possible to implement multiplex
iLAMP assays for detecting multiple proteins in a sam-
ple. The application of nanoprobes for detecting iLAMP
products is depicted in Figure 2.
Integration with liposome
Liposomes are spherical micro/nanostructures made of
lipid bilayers and can be filled with various molecules.
In other words, liposomes have hydrophilic cores,
which can be loaded with hydrophilic agents [55]. They
can be loaded with thousands of DNA molecules as sig-
nal molecules, and at the time of detection liposome
membrane can be destructed in order to release the
signal DNA molecules. Signal DNA molecules released
then can be readily amplified with LAMP method.
Application of DNA-loaded liposomes instead of
single signal DNA increases the sensitivity of iLAMPFigure 4 Integration of microfluidics with iLAMP (microfluidics-iLAMPdrastically. Releasing several molecules of signal DNA
from liposomes increases the possibility of recognition
of target signal DNA by LAMP enzyme (Bst DNA poly-
merase). In fact, DNA-loaded liposomes serve as the
first step of signal amplification, and LAMP serves as
the second. Furthermore, application of nanoprobes for
detection of LAMP products adds the third step of sig-
nal amplification to the iLAMP reaction. It can en-
hance the sensitivity of iLAMP several times. This
significant increase of sensitivity can be useful for
detection of very low concentration proteins and detec-
tion of target proteins in complex samples by overcom-
ing the inhibition of Bst DNA polymerase by inhibitors
existing in the sample.
The application of DNA-encapsulated liposome has
been reported in a study, where a modified version of
iPCR, called as immunoliposome-PCR, has been utilized
to measure the concentration of carcinoembryonic anti-
gen (CEA) in human serum. This study showed that
this novel method is 1,500 times more sensitive than
common methods of CEA detection [56]. Similarly,
immunoliposome-LAMP method can be designed to
considerably enhance the detection limit of iLAMP.
More layer of signal enhancement in immunoliposome-
LAMP can be reached through application of liposomal
networks, instead of application of one liposome for de-
tection of target protein. Practically, this network can be
constructed through application of biotin-streptavidin in-
teractions. For construction of liposomal network, biotin-
embedded liposomes, pre-loaded with signal DNA mol-
ecules, can be linked to each other through streptavidin
or avidin bridges. This improvement increases theplatform).
Figure 5 Application of aptamer instead of antibody in iLAMP (aptamer-iLAMP platform).
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single-immunoliposome-LAMP (Figure 3).
Integration with microfluidic devices
Microfluidics, the handling of fluids in the micro/nano-
scale, is an evolving field of analytical sciences, which
allow precise control of fluid behavior under controlled
conditions [57]. This precise control of fluids represents
microfluidic-based devices as an advanced tool for analysis
of biological samples. In fact, such devices have advantages
that offer greater potential for the diagnostic tests to be
practical for the clinical purposes. These advantages in-
clude the ability to handle small sample sizes with minimal
reagents, the potential applications in field use or point-
of-care (POC) usage, the possibility of integrating with
biosensors or sample-pre-treatment modules, which in-
creases the efficiency of the assays and reduces cross-
contamination, decrease in the cost of test and short assay
time [58,59]. Due to the advantages of microfluidic devices
in the design of diagnostic methods, the integration of
microfluidic-based devices with iLAMP increases its ap-
plicability in the clinical area. The scheme of microfluidic
chip-based iLAMP platform is depicted in Figure 4.
Integration with aptamer (aptamer-iLAMP)
One of the challenges of current nucleic acid-based de-
tection of proteins is the availability of antibody-signal
DNA conjugates. In practice, the preparation of such
conjugates is challenging, and sometimes the producedFigure 6 Possible applications of iLAMP technique.conjugates do not have the required specificity and pro-
duce background noise [20]. Due to the application of
such conjugates in iLAMP, this problem also remains in
iLAMP method. However, this problem can be solved by
application of aptamers, the nucleic acids with the ability
of specific recognition of their target molecules in the
folded conformation instead of antibodies in iLAMP. Be-
side this advantage, aptamers have many benefits over
antibodies. These advantages include low cost, ease of
preparation, high stability, the possibility of reversible
denaturing, the possibility of on-demand changes of the
properties, the possibility of aptamer identification for
toxins as well as molecules that do not elicit good im-
mune responses, the minimum batch-to-batch difference
in the performance, and the possibility of precise conju-
gation with various reporter molecules [60,61]. Aptamers
also have high sensitivity and specificity toward their tar-
gets. They have the equilibrium dissociation constants
(Kd) of the pico- to micromolar range and can discrim-
inate subtle differences in the structure of their targets,
even better than antibodies [62,63], while some disad-
vantages can limit the application of antibodies. Labori-
ous production, limited shelf-life, restriction in the
production of different types of antibodies due to the
limitations in the growth of some hybridomas, batch-to-
batch differences in the performance of the same anti-
body, and inability to modify the kinetic parameters of
antibody-target interactions are the main drawbacks of
the use of antibodies [63].
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aptamer-iLAMP method can be considered as an im-
proved configuration of iLAMP technique. In addition,
the aptamers used can serve as both recognition and sig-
nal molecule for direct detection of the target without
need for antibody-DNA conjugates (Figure 5).
Possible limitations of iLAMP and their solutions
Like any new detection method, iLAMP may have some
potential problems. One problem can be the challenging
preparation of antibody-DNA conjugates. As discussed
in the subsection ‘Integration with aptamer (aptamer-
iLAMP)’ this problem can be solved by using aptamer
molecules instead of antibody-DNA conjugates. In this
case, aptamer can be used both for recognition and as a
substrate of signal amplification (Figure 5).
The second problem may be related to the difficulty in
the designing of LAMP primers. This problem can be alle-
viated by using a special software, called Primer Explorer
(primerexplorer.jp/e/), which is designed specifically for
LAMP primers.
Another problem may be related to the preparation of
gold and silver nanoprobes. This step may add some
complicacy in the procedure of protein detection with
iLAMP-nanoprobe method. However, if the same DNA
signal is used for different protein targets, the nanop-
robes are the same for different proteins. This can lower
the need for preparation of new nanoprobes for every
protein target.
Importance of the hypothesis
The proposed method can find various applications in the
field of protein detection science. Due to ultra-high speci-
ficity and sensitivity of iLAMP, it can be used for detection
of proteins with ultra-low concentrations (hardly de-
tectable with common immunoassay methods), which
is of high importance. These proteins include cancer
biomarkers, viral proteins, toxins, hormones, allergens,
pollutants, and small non-protein molecules (can be de-
tected by aptamer-LAMP version) [20].
The proposed method can also be used for the detec-
tion of the surface antigens of different cells. In this case,
particular antigens can be used to specifically detect the
target cells for various purposes. Stem cells, rare circu-
lating cells, such as circulating tumor [64] and fetal cells
[65], and different subtypes of particular cells [66] can
be easily detected using different configurations of
iLAMP.
The ultra-high sensitivity and specificity of iLAMP
method allows one to identify many diseases as early as
possible. This issue has a great importance in the case of
lethal diseases like cancer due to the fact that early de-
tection can increase the chance of successful treatments
[67] (Figure 6).Summary and future perspectives
With the application of iLAMP method, many technical
problems of current nucleic acid-based methods for pro-
tein detection can be avoided. This new method thus
can find many potential applications in detecting low-
concentration proteins that are vital for monitoring hu-
man diseases and pathological states in the human body.
In conclusion, considering the rapidness, simplicity, and
affordability with no need for expert personnel and
specific instrument, iLAMP method can be an important
alternative in point-of-care diagnostic technique, par-
ticularly in low-resource laboratories.
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